Boston Scientific is trading at $48.71 (+4.24%) as broader U.S. equities rally in a risk-on session.
- The advance appears driven by market-wide strength rather than company-specific catalysts, with the S&P 500 up 0.64% and the Nasdaq gaining 0.84%.
- Investors are showing follow-through interest in growth-oriented equities following the company's July 29 earnings report.
- The Dow Jones Industrial Average is also firmer, rising 1.11%, supporting the positive momentum for the stock.